JAK-STAT and JAK-PI3K-mTORC1 pathways regulate telomerase transcriptionally and posttranslationally in ATL cells

Molecular Cancer Therapeutics

Volumn 11, Issue 5, 2012, Pages 1112-1121

  Yamada, Osamu ^a   Ozaki, Kohji ^a   Akiyama, Masaharu ^c   Kawauchi, Kiyotaka ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; JANUS KINASE; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; S6 KINASE; SMALL INTERFERING RNA; STAT5 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; T CELL LEUKEMIA; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; INTERLEUKIN-2; JANUS KINASES; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN BINDING; PROTEINS; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; STAT5 TRANSCRIPTION FACTOR; TELOMERASE;

EID: 84862747046     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-11-0850     Document Type: Article

References (36)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980;77:7415-9. (Pubitemid 11131140)
2. Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita KI, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981;78:6476-80. (Pubitemid 12179735)
3. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 1982;79:2031-5. (Pubitemid 12088563)
4. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol 1991;79:428-37.
5. Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T, et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010;115:4337-43.
6. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001;344:1038-42. (Pubitemid 32267973)
7. Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, et al. Transcriptional activation of hTERT through the NFkappaB pathway in HTLV-I-transformed cells. Blood 2004;104:2523-31. (Pubitemid 39331856)
8. Gabet AS, Mortreux F, Charneau P, Riou P, Duc-Dodon M, Wu Y, et al. Inactivation of hTERT transcription by Tax. Oncogene 2003;22:3734-41. (Pubitemid 36760735)
9. Yoshida M. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 2005;24:5931-7. (Pubitemid 43086111)
10. Maeda M, Arima N, Daitoku Y, Kashihara M, Okamoto H, Uchiyama T, et al. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Blood 1987;70:1407-11. (Pubitemid 18026146)
11. Chen J, Petrus M, Bryant BR, Phuc Nguyen V, Goldman CK, Bamford R, et al. Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia. Blood 2010;116:5948-56.
12. Bellon M, Nicot C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 2008;112:2946-55.
13. Ellery JM, Nicholls PJ. Alternate signalling pathways from the interleukin-2 receptor. Cytokine Growth Factor Rev 2002;13:27-40. (Pubitemid 34436960)
14. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, et al. Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci U S A 1997;94:13897-902. (Pubitemid 28009681)
15. Nakatake M, Kakiuchi Y, Sasaki N, Murakami-Murofushi K, Yamada O. STAT3 and PKC differentially regulate telomerase activity during megakaryocytic differentiation of K562 cells. Cell Cycle 2007;6:1496-501.
16. Yamada O, Ozaki K, Furukawa T, Machida M, Wang YH, Motoji T, et al. Activation of STAT5 confers imatinib resistance on leukemic cells through the transcription of TERT and MDR1. Cell Signal 2011;23:1119-27.
17. Washiyama M, Nishigaki K, Ahmed N, Kinpara S, Ishii Y, Kanzawa N, et al. IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines. FEBS Lett 2007;581:5207-12. (Pubitemid 350018747)
18. Kinpara S, Hasegawa A, Utsunomiya A, Nishitsuji H, Furukawa H, Masuda T, et al. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon. J Virol 2009;83:5101-8.
19. Isogawa M, Higuchi M, Takahashi M, Oie M, Mori N, Tanaka Y, et al. Rearranged NF-kappa B2 gene in an adult T-cell leukemia cell line. Cancer Sci 2008;99:792-8. (Pubitemid 351448085)
20. Tanaka Y, Yoshida A, Tozawa H, Shida H, Nyunoya H, Shimotohno K. Production of a recombinant human T-cell leukemia virus type-I transactivator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer 1991;48:623-30.
21. Yamada O, Takanashi M, Ujihara M, Mizoguchi H. Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change. Leuk Res 1998;22:711-7. (Pubitemid 28327477)
22. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.
23. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997;25:2595-7. (Pubitemid 27298154)
24. Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Multistep regulation of telomerase during differentiation of HL60 cells. J Leukoc Biol 2008;83:1240-8. (Pubitemid 351960356)
25. Yoshida M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 2001;19:475-96. (Pubitemid 32368043)
26. Fuhrer DK, Yang YC. Complex formation of JAK2 with PP2A, P13K, and Yes in response to the hematopoietic cytokine interleukin-11. Biochem Biophys Res Commun 1996;224:289-96. (Pubitemid 26268183)
27. Al-Shami A, Naccache PH. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Involvement of Jak2 in the stimulation of phosphatidylinositol 3-kinase. J Biol Chem 1999;274:5333-8. (Pubitemid 29109175)
28. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005;2:27.
29. Malek TR, Castro I. Interleukin-2 receptor signaling: At the interface between tolerance and immunity. Immunity 2010;33:153-65.
30. Blagosklonny MV. Hsp-90-associated oncoproteins: Multiple targets of geldanamycin and its analogs. Leukemia 2002;16:455-62. (Pubitemid 34449725)
31. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999;13:817-26. (Pubitemid 29169841)
32. Kawauchi K, Ihjima K, Yamada O. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 30-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells. J Immunol 2005;174:5261-9. (Pubitemid 40593164)
33. Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M, Nelson BH, et al. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol Cell Biol 2000;20:7109-20.
34. Moon JJ, Nelson BH. Phosphatidylinositol 3-kinase potentiates, but does not trigger, T cell proliferation mediated by the IL-2 receptor. J Immunol 2001;167:2714-23. (Pubitemid 32768902)
35. Arima N, Daitoku Y, Yamamoto Y, Fujimoto K, Ohgaki S, Kojima K, et al. Heterogeneity in response to interleukin 2 and interleukin 2-producing ability of adult T cell leukemic cells. J Immunol 1987;138:3069-74. (Pubitemid 17072795)
36. Santos FP, Verstovsek S. JAK2 inhibitors: What's the true therapeutic potential? Blood Rev 25:53-63.